The lipid paradox in neuroprogressive disorders: Causes and consequences

Morris, Gerwyn, Berk, Michael, Walder, Ken, O’Neil, Adrienne, Maes, Michael, Puri, Basant K.·2021·Neuroscience & Biobehavioral Reviews
DOI 10.1016/j.neubiorev.2021.06.017

Cites (563)

Items 401–558 of 558

  1. Glabridin Protects Paraoxonase 1 from Linoleic Acid Hydroperoxide Inhibition via Specific Interaction: A Fluorescence-Quenching Study
    Dana Atrahimovich, Jacob Vaya, Hagai Tavori, Soliman Khatib · 2012 · Journal of Agricultural and Food Chemistry
  2. Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction
    Francesca Zimetti, Stefano DE VUONO, Monica Gomaraschi, Maria Pia Adorni, Elda Favari, Nicoletta Ronda, Maria Anastasia Ricci, Fabrizio Veglia, Laura Calabresi, Graziana Lupattelli · 2017 · Journal of Lipid Research
  3. Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284
    Hagai Tavori, Michael Aviram, Soliman Khatib, Ramadan Musa, Dalit Mannheim, Ron Karmeli, Jacob Vaya · 2010 · Free Radical Biology and Medicine
  4. Lipoprotein-Associated Phospholipase A2(Lp-PLA2) and Future Risk of Type 2 Diabetes: Results from the Cardiovascular Health Study
    T. L. Nelson, Mary Lou Biggs, Jorge R. Kizer, Mary Cushman, John E. Hokanson, Curt Daniel Furberg, Kenneth Jay Mukamal · 2012 · The Journal of Clinical Endocrinology & Metabolism
  5. Effect of dietary lipids on paraoxonase-1 activity and gene expression
    Gianna Ferretti, Tiziana Bacchetti · 2011 · Nutrition Metabolism and Cardiovascular Diseases
  6. Role of neutrophils in atherogenesis: an update
    Aldo Pende, Nathan Artom, Maria Bianca Bertolotto, Fabrizio Montecucco, Franco Dallegri · 2015 · European Journal of Clinical Investigation
  7. Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis
    Estela Salagre, Adriana Fernanda K. Vizuete, Marina Concli Leite, Daniel J. Brownstein, Amelia J. McGuinness, Felice N. Jacka, Seetal Dodd, Brendon Stubbs, C.A. Köhler, Eduard Vieta et al. · 2017 · European Psychiatry
  8. Early Life Trauma Predicts Affective Phenomenology and the Effects are Partly Mediated by Staging Coupled with Lowered Lipid-Associated Antioxidant Defences
    Michael H. J. Maes, Ana Carolina Congio, Juliana Brum Moraes, Kamila Landucci Bonifácio, Décio Sabbatini Barbosa, Heber Odebrecht Vargas, Gerwyn Morris, Basant K. Puri, Ana Paula Michelin, Sandra Odebrecht Vargas Nunes · 2018 · BioMolecular Concepts
  9. Cytosolic Phospholipase A2-α Mediates Endothelial Cell Proliferation and Is Inactivated by Association with the Golgi Apparatus
    Shane P. Herbert, Sreenivasan Ponnambalam, John H. Walker · 2005 · Molecular Biology of the Cell
  10. Group X Secretory Phospholipase A 2 Negatively Regulates ABCA1 and ABCG1 Expression and Cholesterol Efflux in Macrophages
    Preetha Shridas, William M. Bailey, Florence Gizard, Rob Oslund, Michael H. Gelb, Dennis Bruemmer, Nancy R. Webb · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
  11. Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population
    Molly E. Harmon, Matthew J. Campen, Curtis P. Miller, Chris Shuey, Miranda Cajero, Selitá Lucas, Bernadette Pacheco, Esther Erdei, Sandy Ramone, Teddy Nez et al. · 2016 · PLoS ONE
  12. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase
    Loukas D. Tsironis, John V. Mitsios, Haralampos J. Milionis, Moses Elisaf, Alexandros D. Tselepis · 2004 · Cardiovascular Research
  13. APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm
    Diego Martínez-López, Emilio Camafeita, Lídia Cedó, Raquel Roldán-Montero, Inmaculada Jorge, Fernando Jose Garcia-Marques, María Gómez‐Serrano, Elena Bonzón‐Kulichenko, Francisco Blanco‐Vaca, Luis Miguel Blanco‐Colio et al. · 2019 · EBioMedicine
  14. Lipid Paradox in Rheumatoid Arthritis: Changes With Rheumatoid Arthritis Therapies
    Matxalen Amezaga, Maria Eugenia Suarez-Almazor · 2012 · Current Rheumatology Reports
  15. CANTOS
    Borja Ibáñez, Valentı́n Fuster · 2017 · Circulation Research
  16. Lipid composition of circulating multiple-modified low density lipoprotein
    Emile Zakiev, Vasily N. Sukhorukov, Alexandra А. Melnichenko, Igor Alexandrovich Sobenin, Ekaterina A. Ivanova, Alexander Nikolaevich Orekhov · 2016 · Lipids in Health and Disease
  17. Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.
    Jutta Dierkes, Claus H. Luley, Sabine Westphal · 2007 · PubMed Central
  18. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: Beyond aspirin and clopidogrel
    Mauricio G. Cohen, Joseph S. Rossi, Jennifer M. Garbarino, Regina Bowling, Alison A. Motsinger‐Reif, Carl Schuler, Allison G. Dupont, Don A. Gabriel · 2011 · Thrombosis Research
  19. Proatherogenic modification of LDL by surface-bound myeloperoxidase
    Sokolov Av, Valeria A. Kostevich, Olga L. Runova, Irina V. Gorudko, V. B. Vasilyev, Cherenkevich Sn, Oleg M. Panasenko · 2014 · Chemistry and Physics of Lipids
  20. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease
    Kei Yunoki, Takahiko Naruko, Mayumi Inaba, Takeshi Inoue, Masashi Nakagawa, Kenichi Sugioka, Masahiko Ohsawa, Yoko Iwasa, Ryushi Komatsu, Akira Itoh et al. · 2013 · Atherosclerosis
  21. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
    Atena Variji, Yasaman Shokri, Samane Fallahpour, Mehryar Zargari, Babak Bagheri, Saeid Abediankenari, Ahad Alizadeh, Abdolkarim Mahrooz · 2018 · Atherosclerosis
  22. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes
    Mike Sampson, Simon Braschi, Gavin A Willis, SIAN B. ASTLEY · 2005 · Clinical Science
  23. Higher concentration of interleukin 6 - A possible link between major depressive disorder and childhood abuse
    Munjiza, Ana, Kostic, Milutin, Pesic, Danilo, Gajic, Milan, Markovic, Ivanka, Tosevski, Dusica Lecic · 2018 · Psychiatry Research
  24. Absence of 12/15 Lipoxygenase Reduces Brain Oxidative Stress in Apolipoprotein E-Deficient Mice
    Cinzia Maria Chinnici, Yuemang Yao, Tao Ding, Colin D. Funk, Domenico Praticò · 2005 · American Journal Of Pathology
  25. Lipopolysaccharide downregulates CD91/low-density lipoprotein receptor-related protein 1 expression through SREBP-1 overexpression in human macrophages
    Paula Costales, José Castellano, Elena Revuelta‐López, Roi Cal, Rosa Aledo, O. Llampayas, Laura Nasarre, Candido Juárez, Lina Badimón, Vicenta Llorente‐Cortés · 2012 · Atherosclerosis
  26. Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis
    Ayman Farid, Yoichiro Horii · 2012 · Lipids in Health and Disease
  27. Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)
    Valentine Charlton-Menys, D. J. Betteridge, Helen Martina Colhoun, John Fuller, Michael W. France, G. A. Hitman, Shona J. Livingstone, H. A. W. Neil, Connie B. Newman, Michael J. Szarek et al. · 2008 · Diabetologia
  28. Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis
    Kwok Leung Ong, Margaret J. Morris, Robyn L. McClelland, Jayanthi Maniam, Matthew Allison, K-a Rye · 2016 · Translational Psychiatry
  29. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms
    Zsuzsanna S. Nagy, Zsolt Czimmerer, Attila Szántó, László Nagy · 2013 · Immunobiology
  30. The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke
    Małgorzata Pawelczyk, H Chmielewski, Beata Kaczorowska, Monika Przybyła, Zbigniew Baj · 2015 · Archives of Medical Science
  31. Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases
    Dominik Maria Schulte, K Paulsen, K Türk, Burkhard Brandt, Sandra Freitag‐Wolf, I Hagen, Rainald A. Zeuner, JO Schröder, Wolfgang Lieb, André Franke et al. · 2018 · Nutrition Metabolism and Cardiovascular Diseases
  32. Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders
    Luciano Ribeiro Filgueiras, C. Henrique Serezani, Sônia Jancar · 2015 · Frontiers in Immunology
  33. Unraveling the PAF-AH/Lp-PLA2 controversy
    Diana M. Stafforini, Guy A. Zimmerman · 2014 · Journal of Lipid Research
  34. Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues
    Junhua Zhou, Brian Lam, Sudeshna Guha Neogi, Giles S.H. Yeo, Elena A B Aisha Azizan, Morris Jonathan Brown · 2016 · Hypertension
  35. TNF-α decreases lipoprotein lipase activity in 3T3-L1 adipocytes by up-regulation of angiopoietin-like protein 4
    Elena Makoveichuk, Evelina Vorrsjö, Thomas Olivecrona, Gunilla Olivecrona · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  36. The role of PON-1, GR, IL-18, and OxLDL in depression with and without posttraumatic stress disorder
    Ewa Alicja Ogłodek · 2017 · Pharmacological Reports
  37. Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis
    Gregory E. Sanda, Agastya D. Belur, Heather Teague, Nehal N. Mehta · 2017 · Current Atherosclerosis Reports
  38. Major depression induces oxidative stress and platelet hyperaggregability
    Monique B. O. Ormonde do Carmo, Antônio Claúdio Mendes‐Ribeiro, Cristiane Matsuura, Vivian Liane Mattos Pinto, Wanda Vianna Mury, Nathalia O. Pinto, Monique Bandeira Moss, Marcos Rochedo Ferraz, Tatiana M.C. Brunini · 2014 · Journal of Psychiatric Research
  39. Effect of statins on platelet function in patients with hyperlipidemia
    Joanna Sikora, Barbara Kostka, Iwona Marczyk, Urszula Krajewska, Maciej Chałubiński, Marlena Broncel · 2013 · Archives of Medical Science
  40. Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial
    Min Xu, San San Ng, George A. Bray, Donna H. Ryan, Frank M. Sacks, Guang Ning, Lu Qi · 2015 · Journal of Nutrition
  41. Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein
    Brawnie Petrov, Ayat Aldoori, Cindy L. James, Kefeng Yang, Guillermo Pérez Algorta, Aejin Lee, Liwen Zhang, Tao Lin, Reem Al Awadhi, Jonathan R. Parquette et al. · 2018 · Translational Psychiatry
  42. Oxidized LDL, homocysteine, homocysteine thiolactone and advanced glycation end products act as pro-oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic effect in ARPE-19 cells
    Kannadasan Anand Babu, Parveen Sen, Narayanasamy Angayarkanni · 2019 · PLoS ONE
  43. Comparison of blood lipid profile/thyroid function markers between unipolar and bipolar depressed patients and in depressed patients with anhedonia or suicidal thoughts
    Meilei Su, Enze Li, Chong Tang, Yongzhi Zhao, Ruqing Liu, Keming Gao · 2019 · Molecular Medicine
  44. Extracellular phospholipases in atherosclerosis
    Sonia‐Athina Karabina, Sarah Gora, Rajai Atout, Ewa Ninio · 2010 · Biochimie
  45. BanI Polymorphism of the Cytosolic Phospholipase A2 Gene and Mood Disorders in the Korean Population
    Chi‐Un Pae, Hye-Sook Yu, Jung-Jin Kim, Chang‐Uk Lee, Soo-Jung Lee, Kyoung‐Uk Lee, Tae‐Youn Jun, In‐Ho Paik, Alessandro Serretti, Chul Lee · 2004 · Neuropsychobiology
  46. Therapeutic potential of interleukin-6 antagonism in bipolar disorder
    Elisa Macedo Brietzke, Morton Aaron Scheinberg, Beny Lafer · 2010 · Medical Hypotheses
  47. Myeloperoxidase modulates human platelet aggregation via actin cytoskeleton reorganization and store-operated calcium entry
    Irina V. Gorudko, Sokolov Av, Ekaterina V. Shamova, Н. А. Грудинина, Elizaveta S. Drozd, Ludmila M. Shishlo, Daria V. Grigorieva, Sergey B. Bushuk, Boris A. Bushuk, С. А. Чижик et al. · 2013 · Biology Open
  48. Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein(a)
    Kathrin Heermeier, Reinhard Schneider, Alexandra N. Heinloth, Christoph Wanner, Stefanie Dimmeler, Jan Galle · 1999 · Kidney International
  49. Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia
    Jean‐Charles Hogue, Benoı̂t Lamarche, Daniel Gaudet, Mathieu Larivière, André J. Tremblay, Jean Bergeron, Isabelle Lemieux, Jean‐Pierre Després, Claude Gagné, Patrick Couture · 2004 · Journal of Lipid Research
  50. Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP)
    Natalya S. Weber, Kristin L. Gressitt, David N. Cowan, David W. Niebuhr, Robert H. Yolken, Emily G. Severance · 2018 · Schizophrenia Research
  51. The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
    Huaqun Zhu, Xiaolin Sun, Lei Zhu, Fanlei Hu, Lianjie Shi, Zhanguo Li, Yin Su · 2014 · Journal of Immunology Research
  52. Myeloperoxidase Potentiates Nitric Oxide-mediated Nitrosation
    Vijaya M. Lakshmi, William Michael Nauseef, Terry V. Zenser · 2004 · Journal of Biological Chemistry
  53. Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis
    Francis Fregonesi Brinholi, Cristiano de Souza Noto, Michael H. J. Maes, Kamila Landucci Bonifácio, Elisa Macedo Brietzke, Vanessa Ota, Ary Gadelha, Quirino Cordeiro, Sintia Iole Belangero, Rodrigo A. Bressan et al. · 2015 · Schizophrenia Research
  54. Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha
    Thierry Roumeguère, Karim Zouaoui Boudjeltia, Sajida Babar, Vincent Nuyens, Alexandre Rousseau, Pierre Van Antwerpen, Jean Ducobu, Eric Wespes, Michel Vanhaeverbeek · 2009 · European Urology
  55. Enhanced M2 macrophage polarization in high n‐3 polyunsaturated fatty acid transgenic mice fed a high‐fat diet
    Mi‐Young Song, Jie Wang, Youngyi Lee, Ju Hyung Lee, Keun-Sang Kwon, Eun Ju Bae, Byung‐Hyun Park · 2016 · Molecular Nutrition & Food Research
  56. Lp-PLA2 silencing protects against ox-LDL-induced oxidative stress and cell apoptosis via Akt/mTOR signaling pathway in human THP1 macrophages
    Huadong Zheng, Da-Jiang Cui, Xiaojuan Quan, Weilin Yang, YingNa Li, Lin Zhang, Enqi Liu · 2016 · Biochemical and Biophysical Research Communications
  57. Effect of Niacin on High-Density Lipoprotein Apolipoprotein A-I Kinetics in Statin-Treated Patients With Type 2 Diabetes Mellitus
    Jing Pang, Dick C. Chan, Sandra J. Hamilton, Vijay S. Tenneti, Gerald Francis Watts, P. Hugh R. Barrett · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
  58. Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins
    Wei-Ming Chen, W. Sheu, Pei-Chi Tseng, Tzong-Shyuan Lee, Wen-Jane Lee, Pey-Jium Chang, A. Chiang · 2016 · PLoS ONE
  59. The atheroprotective role of lipoxin A4 prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway
    Mai, Jingting, Liu, Wenhao, Fang, YongBiao, Zhang, Shujuan, Qiu, Qiong, Yang, Ying, Wang, Xiaoqiao, Huang, TuCheng, Zhang, HaiFeng, Xie, Yong et al. · 2018 · Atherosclerosis
  60. Statins do not decrease small, dense low-density lipoprotein.
    Cheol Ung Choi, Hong Seog Seo, Eun Mi Lee, Seung Yong Shin, Un-Jung Choi, Jin Oh Na, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Seung‐Woon Rha et al. · 2010 · PubMed Central
  61. Serum calcium‐independent phospholipase A2 activity in bipolar affective disorder
    Brian M. Ross, Bronwen Hughes, Stephen J. Kish, Jerry J. Warsh · 2006 · Bipolar Disorders
  62. Low unesterified:esterified eicosapentaenoic acid ( EPA ) plasma concentration ratio is associated with bipolar disorder episodes, and omega‐3 plasma concentrations are altered by treatment
    Erika F.H. Saunders, Aubrey Reider, Gagan Singh, Alan J. Gelenberg, Stanley Isaac Rapoport · 2015 · Bipolar Disorders
  63. Harmful and protective roles of group V phospholipase A2: Current perspectives and future directions
    Sachin Kumar Samuchiwal, Barbara Balestrieri · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  64. Group X Secretory Phospholipase A2 Enhances TLR4 Signaling in Macrophages
    Preetha Shridas, William M. Bailey, Kayla R. Talbott, Rob Oslund, Michael H. Gelb, Nancy R. Webb · 2011 · The Journal of Immunology
  65. Oxidised phospholipids as biomarkers in human disease
    Maria Philippova, Thérèse J. Resink, Paul Erné, Valerie Bochkov · 2014 · Swiss Medical Weekly
  66. Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification
    Marit Westerterp, Jimmy F.P. Berbée, Dianne J. M. Delsing, Miek C. Jong, Marion J. Gijbels, Vivian E.H. Dahlmans, Erik H. Offerman, Johannes Anthonius Romijn, Louis M. Havekes, Patrick C.N. Rensen · 2007 · Journal of Lipid Research
  67. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A2 in patients with stable angina
    Grzegorz Gajos, J Zalewski, Magdalena Mostowik, Ewa Konduracka, Jadwiga Maria Nessler, Anetta Undas · 2013 · Nutrition Metabolism and Cardiovascular Diseases
  68. Lp-PLA2: A New Target for Statin Therapy
    Lynne T. Braun, Michael H. Davidson · 2010 · Current Atherosclerosis Reports
  69. Mitogenic Activity of Oxidized Lipoprotein (a) on Human Vascular Smooth Muscle Cells
    Norio Komai, Ryuichi Morishita, Shingo Yamada, Mitsuru Oishi, Sota Iguchi, Motokuni Aoki, Minako Sasaki, Ikunosuke Sakurabayashi, Jitsuo Higaki, Toshio Ogihara · 2002 · Hypertension
  70. Homocysteine
    Wen‐Ming Wang, Hongzhong Jin · 2017 · Chinese Medical Journal
  71. Lowering the n-6/n-3 PUFAs ratio inhibits the formation of THP-1 macrophage-derived foam cell
    Zhixiu Song, Hui Xia, Ligang Yang, Shaokang Wang, Guiju Sun · 2018 · Lipids in Health and Disease
  72. Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
    Adam Zalewski, Colin H. Macphee, Jennifer A Nelson · 2005 · Cardiovascular & Haematological Disorders - Drug Targets
  73. Polyunsaturated Fatty Acids Influence LPS-Induced Inflammation of Fish Macrophages Through Differential Modulation of Pathogen Recognition and p38 MAPK/NF-κB Signaling
    Qingfei Li, Kun Cui, Mengjiao Wu, Dan Xu, Kangsen Mai, Qinghui Ai · 2020 · Frontiers in Immunology
  74. Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-ß: A Protective Role of Melatonin
    Sergio Rosales‐Corral, Gabriela del Carmen López-Armas, José Alfonso Cruz-Ramos, Valery Melnikov, Dun‐Xian Tan, Lucien C. Manchester, Ruben Munoz, Russel Joseph Reiter · 2012 · International Journal of Alzheimer s Disease
  75. Erratum to “Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)” [Atherosclerosis 200 (2008) 135–140]
    Saito, Yasushi, Yokoyama, Mitsuhiro, Origasa, Hideki, Matsuzaki, Masunori, Matsuzawa, Yuji, Ishikawa, Yuichi, Oikawa, Shinichi, Sasaki, Jun, Hishida, Hitoshi, Itakura, Hiroshige et al. · 2009 · Atherosclerosis
  76. Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients
    Mickael Essouma, Jean Jacques Noubiap · 2015 · Biomarker Research
  77. Targeting myeloperoxidase in inflammatory atherosclerosis
    Max L. Senders, Willem J. M. Mulder · 2018 · European Heart Journal
  78. Lipoprotein(a) – Link between Atherogenesis and Thrombosis
    Danica D Labudović, Irena Kostovska, Katerina Tosheska Trajkovska, Svetlana Cekovska, Julijana Brezovska Kavrakova, Sonja Topuzovska · 2019 · Prague Medical Report
  79. Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?
    Natalie C. Ward, Karam Kostner, DAVID R. SULLIVAN, Paul John Nestel, Gerald Francis Watts · 2019 · Journal of Clinical Medicine
  80. The Effect of DHA Supplementation on Cognition in Patients with Bipolar Disorder: An Exploratory Randomized Control Trial
    Valentina Ciappolino, Giuseppe Delvecchio, Cecilia Prunas, Angela Andreella, Livio Finos, Elisabetta Caletti, Francesca Marzia Siri, Alessandra Mazzocchi, A. Botturi, Stefano Turolo et al. · 2020 · Nutrients
  81. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study
    Kana Ide, Masaya Koshizaka, Hirotake Tokuyama, Takahiko Tokuyama, Takahiro Ishikawa, Yoshiro Maezawa, Minoru Takemoto, Koutaro Yokote · 2018 · Lipids in Health and Disease
  82. Oxygen‐glucose deprivation activates 5‐lipoxygenase mediated by oxidative stress through the p38 mitogen‐activated protein kinase pathway in PC12 cells
    Cheng‐Tan Li, Wei‐Ping Zhang, Yun‐Bi Lu, San‐Hua Fang, Yumei Yuan, Lingling Qi, Lihui Zhang, Xiao‐Jia Huang, Lei Zhang, Zhong Chen et al. · 2008 · Journal of Neuroscience Research
  83. Serum lipid profile changes after successful treatment with electroconvulsive therapy in major depression: A prospective pilot trial
    Suna Su Aksay, Jan Malte Bumb, Christoph Janke, Ronald Biemann, Katrin Borucki, Florian Lederbogen, Michael Deuschle, Alexander Sartorius, Laura Kranaster · 2015 · Journal of Affective Disorders
  84. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein
    Naoko Sasabe, Yuka Keyamura, Takashi Obama, Nozomi Inoue, Yukihiro Masuko, Yu Igarashi, Toshihiro Aiuchi, Rina Kato, Tomohiro Yamaguchi, Hiroshi Kuwata et al. · 2014 · Lipids in Health and Disease
  85. Methionine oxidized apolipoprotein A‐I at the crossroads of HDL biogenesis and amyloid formation
    Andrzej Witkowski, Gary K.L. Chan, Jennifer C. Boatz, Nancy J. Li, Ayuka P. Inoue, Jaclyn C. Wong, Patrick C.A. van der Wel, Giorgio Cavigiolio · 2018 · The FASEB Journal
  86. Recent insight into the correlation of SREBP-mediated lipid metabolism and innate immune response
    Hyeon Young Park, Hye Suk Kang, Seung‐Soon Im · 2018 · Journal of Molecular Endocrinology
  87. Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control
    Rodrigo López‐Muñoz, Alfredo Molina‐Berríos, Carolina Campos‐Estrada, Patricio Abarca-Sanhueza, Luis Urrutia-Llancaqueo, Miguel Peña-Espinoza, Juan Diego Maya · 2018 · Frontiers in Microbiology
  88. ApoA-I
    Angela M. Devlin, Steven R. Lentz · 2006 · Circulation Research
  89. Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: A preliminary study.
    Murat Semız, Hasan Yücel, Önder Kavakçı, Osman Yıldırım, Ali Zorlu, Mehmet Birhan Yılmaz, Zekeriya Küçükdurmaz, Fatih Canan · 2013 · Europe PMC (PubMed Central)
  90. Serum Oxidized LDL Levels in Type 2 Diabetic Patients with Retinopathy in Mthatha Region of the Eastern Cape Province of South Africa
    Farzana Ganjifrockwala, Jim Thytharayil Joseph, Grace George · 2016 · Oxidative Medicine and Cellular Longevity
  91. Conceptualization of Heterogeneity of Chronic Diseases and Atherosclerosis as a Pathway to Precision Medicine: Endophenotype, Endotype, and Residual Cardiovascular Risk
    V. Genkel, I. Shaposhnik · 2020 · International Journal of Chronic Diseases
  92. Malondialdehyde, lipoprotein-a, lipoprotein ratios, comprehensive lipid tetrad index and atherogenic index as surrogate markers for cardiovascular disease in patients with psoriasis: a case–control study
    Dhaarna Wadhwa, Vikram Kumar Mahajan, Karaninder Singh Mehta, Pushpinder Singh Chauhan, Rajinder S. Yadav, Satya Bhushan, Vikas Mohan Sharma, Anuj Sharma, Aditi Sharma, Shailja Chauhan · 2019 · Archives of Dermatological Research
  93. Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease
    Elisabeth C. Samouilidou, Vassilis Kostopoulos, Augustina Liaouri, Eva Kiousi, Kyriaki Vassiliou, Eirini Bountou, Eirini J. Grapsa · 2016 · Renal Failure
  94. Age-Dependent Paraoxonase 1 (PON1) Activity and LDL Oxidation in Wistar Rats during Their Entire Lifespan
    Dileep Kumar, Syed Ibrahim Rizvi · 2014 · The Scientific World JOURNAL
  95. AMP-activated protein kinase mediates the effects of lipoprotein-associated phospholipase A2 on endothelial dysfunction in atherosclerosis
    Li Yang, Hongliang Cong, Shufeng Wang, Ting Liu · 2017 · Experimental and Therapeutic Medicine
  96. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
    Gabrielle Fredman · 2019 · Frontiers in Pharmacology
  97. The Effects of Niacin on Lipoprotein Subclass Distribution
    John M. Morgan, Christina M. Carey, Anne Lincoff, David M. Capuzzi · 2004 · Preventive Cardiology
  98. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients
    Elżbieta Kimak, Magdalena Hałabiś, Iwona Baranowicz-Gąszczyk, Janusz Solski, Andrzej Książek · 2011 · Journal of Zhejiang University SCIENCE B
  99. Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages
    Konstantinos P. Markakis, Maria K. Koropouli, Stavroula Grammenou, Ewoud C. van Winden, Andromaxi A. Dimitriou, Constantinos Alexandros Demopoulos, Alexandros D. Tselepis, Eleni Kotsifaki · 2010 · Journal of Lipid Research
  100. Defective Nitric Oxide–Cyclic Guanosine Monophosphate Signaling in Patients With Bipolar Disorder
    Paula C. Fontoura, Vivian Liane Mattos Pinto, Cristiane Matsuura, Ângela Castro Resende, Graziele Freitas de Bem, Marcos Rochedo Ferraz, Elie Cheniaux, Tatiana M.C. Brunini, Antônio Claúdio Mendes‐Ribeiro · 2012 · Psychosomatic Medicine
  101. Human group X secreted phospholipase A2 induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms
    Rajai Atout, Sonia‐Athina Karabina, Sandra Dollet, Martine Carreras, Christine Payré, Patrice André, Gerard J. Lambeau, Vincent Lotteau, Ewa Ninio, Laure Perrin‐Cocon · 2012 · Atherosclerosis
  102. Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposure
    Jimmy Lee, Valerie Powell, Gary J. Remington · 2014 · Schizophrenia Research
  103. Myeloperoxidase Oxidized LDL Interferes with Endothelial Cell Motility through miR-22 and Heme Oxygenase 1 Induction: Possible Involvement in Reendothelialization of Vascular Injuries
    Jalil Daher, Maud Martin, Alexandre Rousseau, Vincent Nuyens, Hussein Fayyad‐Kazan, Pierre Van Antwerpen, Guy Courbebaisse, Philippe Martiat, Bassam M. Badran, Frank Dequiedt et al. · 2014 · Mediators of Inflammation
  104. Dietary Polyunsaturated Fatty Acids Promote Neutrophil Accumulation in the Spleen by Altering Chemotaxis and Delaying Cell Death
    Sara L. Svahn, Saray Gutiérrez, Marcus A. Ulleryd, Intawat Nookaew, Veronica Osla, Fredrik Beckman, Staffan Nilsson, Anna Karlsson, John‐Olov Jansson, Maria E. Johansson · 2019 · Infection and Immunity
  105. Role of the lipoxin A4 receptor in the development of neutrophil extracellular traps in Leishmania infantum infection
    Furong Wei, Wenci Gong, Junyun Wang, Yue-tao Yang, Jianxiu Liu, Yanjuan Wang, Jianping Cao · 2019 · Parasites & Vectors
  106. Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatin
    Shigemasa Tani, Atsuhiko Takahashi, Ken Nagao, Atsushi Hirayama · 2014 · Heart and Vessels
  107. Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement
    Dongdan Zheng, Fanfang Zeng, Anping Cai, Huocheng Liao, Ling Liu, Ruofeng Qiu, Rulin Xu, Chun Xiao, Weiyi Mai · 2014 · Lipids in Health and Disease
  108. Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect
    Gerd Hörl, Harald Froehlich, Ulrika Ferstl, Gerhard Ledinski, Josepha S. Binder, Gerhard Cvirn, Tatjana Stojaković, Michael A Trauner, Christoph Koidl, Erwin Tafeit et al. · 2016 · PLoS ONE
  109. Pathological phenotypes of LDL particles
    Ulrich Laufs, Oliver Weingärtner · 2018 · European Heart Journal
  110. Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects
    Eseng Lai, Jules I. Schwartz, Aimee L. Dallob, Patricia A. Jumes, Fang Liu, Walter K. Kraft, Jane E. Royalty, Jeffrey Chodakewitz, Christine McCrary Sisk, Waldemar Radziszewski et al. · 2010 · Platelets
  111. Systematic analysis of the molecular mechanism underlying atherosclerosis using a text mining approach
    Dan Xi, Jinzhen Zhao, Wenyan Lai, Zhigang Guo · 2016 · Human Genomics
  112. Myeloperoxidase and Atherosclerosis
    Vaijinath S. Kamanna, Shobha H. Ganji, Moti L. Kashyap · 2013 · Current Cardiovascular Risk Reports
  113. Benefits of Omega-3 Fatty Acids Supplementation on Serum Paraoxonase 1 Activity and Lipids Ratios in Polycystic Ovary Syndrome
    Elahe Mohammadi, Maryam Rafraf · 2012 · Europe PMC (PubMed Central)
  114. BanI polymorphism of cytosolic phospholipase A2 gene and somatic symptoms in medication-free acute depressed patients
    Jane Pei‐Chen Chang, Ta‐Wei Guu, Yi‐Chih Chen, Piotr Gałecki, Anna Walczewska, Kuan‐Pin Su · 2017 · Prostaglandins Leukotrienes and Essential Fatty Acids
  115. Trichinella spiralis: Infection changes serum paraoxonase-1 levels, lipid profile, and oxidative status in rats
    Shogo Mido, Eman Mohamed Fath, Ayman Farid, Nariaki Nonaka, Yuzaburo Oku, Yoichiro Horii · 2012 · Experimental Parasitology
  116. Prostaglandin E receptor‐4 receptor mediates endothelial barrier–enhancing and anti‐inflammatory effects of oxidized phospholipids
    Olga Oskolkova, Grzegorz Gawlak, Yufeng Tian, Yunbo Ke, Nicolene A. Sarich, Sophia Son, Katrin I. Andreasson, Valery N. Bochkov, Anna A. Birukova, Konstantin G. Birukov · 2017 · The FASEB Journal
  117. Molecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the Structure
    Prabhavathi Srinivasan, Brian J. Bahnson · 2010 · Pharmaceuticals
  118. Therapeutic Lowering of Lipoprotein(a)
    Michael B. Boffa, Marlys L. Koschinsky · 2018 · Circulation Genomic and Precision Medicine
  119. The association between mean platelet volume levels and poststroke depression
    Huihua Qiu, Yuntao Liu, Hongfei He, Yuemin Wu, Weilei He, Guiqian Huang, Jincai He · 2018 · Brain and Behavior
  120. The investigation of cytosolic phospholipase A2 using ELISA
    Donald J. MacDonald, Rose M. Boyle, Alastair C. A. Glen, Brian M. Ross, A.I.M. Glen, P.E. Ward, Siofradh B McKinney, M. A. Peterkin · 2004 · Prostaglandins Leukotrienes and Essential Fatty Acids
  121. Positive association between plasma levels of oxidized low‐density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end‐stage renal disease
    Chizuko Kitabayashi, Takahiko Naruko, Kenichi Sugioka, Kei Yunoki, Masashi Nakagawa, Mayumi Inaba, Masahiko Ohsawa, Yoshio Konishi, Masahito Imanishi, Takeshi Inoue et al. · 2013 · Hemodialysis International
  122. The impact of bacteremia on lipoprotein concentrations and patient’s outcome: a retrospective analysis
    Alex Pizzini, Katharina Kurz, Dorothea Orth‐Höller, Manfred Fille, Jasmin Rabensteiner, Fabian Lunger, Lukas Lunger, Christoph Tschurtschenthaler, Ivan Tancevski, Robert Krause et al. · 2019 · European Journal of Clinical Microbiology & Infectious Diseases
  123. Membrane receptor MerTK is a newly identified transcriptional regulator that associates to chromatin as nanoclusters during human DC differentiation
    Kyra J. E. Borgman, Georgina Flórez‐Grau, Maria Aurelia Ricci, Carlo Manzo, Melike Lakadamyali, Alessandra Cambi, Daniel Benítez‐Ribas, Felix Campelo, M.F. Garcia Parajo · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  124. Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients
    Xiang Zhou, Tao Long, Gretchen L. Haas, Hualin Cai, Jeffrey K. Yao · 2020 · Frontiers in Neuroscience
  125. Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis
    Sandra Wagner, Mugurel Apetrii, Ziad A. Massy, Marcus Edi Kleber, Graciela E. Delgado, Hubert Scharnagel, Winfried März, Marie Metzger, Patrick Rossignol, Alan G. Jardine et al. · 2016 · Free Radical Research
  126. Oxidative and/or Inflammatory Thrust Induced by Silver Nanoparticles in Rabbits: Effect of Vitamin E or NSAID Administration on Semen Parameters
    Giulia Collodel, Simona Mattioli, Elena Moretti, Daniela Cerretani, Lucia Micheli, Anna Ida Fiaschi, Laura Menchetti, Gabriele Brecchia, Cesare Castellini · 2020 · Mediators of Inflammation
  127. The Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects
    Kazuhiko Kotani · 2012 · Journal of Clinical Medicine Research
  128. LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.
    Kazuhiko Kotani, Kokoro Tsuzaki, Nobuyuki Taniguchi, Naoki Sakane · 2012 · Europe PMC (PubMed Central)
  129. Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages
    Lígia Shimabukuro Okuda, Rodrigo Tallada Iborra, Paula Ramos Pinto, Ubiratan Fabres Machado, Maria Lúcia Corrêa‐Giannella, Russell Pickford, Tom M. Woods, Margaret Anne Brimble, Kerry‐Anne Rye, Marisa Passarelli · 2020 · Mediators of Inflammation
  130. Role of oxidized phospholipids in cardiovascular pathology
    David Allen, Devin Hasanally, Amir Ravandi · 2013 · Clinical Lipidology
  131. Association of serum homocysteine and methionine levels with cognition and functioning in bipolar disorder
    Gülsüm Özge Doğanavşargil Baysal, Zehra Gökmen, Halide S Akbas, Buket Ci̇nemre, Özmen Metin, Taha Karaman · 2012 · Turkish Journal of Psychiatry
  132. Circulating malondialdehyde-modified low-density lipoprotein is strongly associated with very small low-density lipoprotein cholesterol concentrations in healthy men
    Ryotaro Takahashi, Akiko Imamura, Mari Yoshikane, Masayuki Suzuki, Xian Wu Cheng, Yasushi Numaguchi, Nobuo Ikeda, Toyoaki Murohara, Kenji Okumura · 2008 · Clinica Chimica Acta
  133. Differential effects of redox‐cycling and arylating quinones on trans‐plasma membrane electron transport
    An S. Tan, Michael V. Berridge · 2008 · BioFactors
  134. Entire Peroxidation Reaction System of Myeloperoxidase Correlates with Progressive Low-Density Lipoprotein Modifications via Reactive Aldehydes in Atherosclerotic Patients with Hypertension
    Quan Liu, Yawen Liu, Jikang Shi, Ming Gao, Yunkai Liu, Yetong Cong, Yong Li, Yonggang Wang, Mingxi Dennis Yu, Yuping Lu et al. · 2018 · Cellular Physiology and Biochemistry
  135. IL-6 AND LIPOPROTEIN (a) [LP(a)] CONCENTRATIONS ARE RELATED ONLY IN PATIENTS WITH HIGH APO(a) ISOFORMS IN MONOCLONAL GAMMOPATHY
    Laura Horváth, Albert Császár, András Falus, Hans Dieplinger, Anna Horváth, E Puskás, Gabriella Halm, Anikó Bányai, Katalin Pálóczi, Elöd László et al. · 2002 · Cytokine
  136. Human group V secretory phospholipase A2 is associated with lipid rafts and internalized in a flotillin-dependent pathway
    Hae Jin Rhee, Liting Ji, SEUNG-HYUK KIM, JONGHO LEE · 2013 · International Journal of Molecular Medicine
  137. Carbohydrate composition of circulating multiple-modified low-density lipoprotein
    Emile Zakiev, Igor Alexandrovich Sobenin, Vasily N. Sukhorukov, Veronika A. Myasoedova, Ekaterina A. Ivanova, Alexander Nikolaevich Orekhov · 2016 · Vascular Health and Risk Management
  138. In Schizophrenia, PON1 Q192R Genotypes and/or Lowered Paraoxonase 1 (PON1) Enzymatic Activity are Significantly Associated with the Deficit Syndrome, Negative Symptoms, Formal Thought Disorders, Psychomotor Retardation, Excitation and Increased IgA Levels to Gram-Negative Microbiota
    Andressa Keiko Matsumoto, Michael H. J. Maes, Annabel Maes, Ana Paula Michelin, Laura de Oliveira Semeão, João Victor de Lima Pedrão, Estefânia Gastaldello Moreira, Buranee Kanchanatawan, Decio S. Barbosa · 2019 · Preprints.org
  139. The Oxidative State of Chylomicron Remnants Influences Their Modulation of Human Monocyte Activation
    Sandra Armengol, Kathleen M. Botham, Charlotte Lawson · 2011 · International Journal of Vascular Medicine
  140. Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis
    Karsten Henrich Weylandt, Christoph Schmöcker, Annika Irmgard Ostermann, Laura Kutzner, Ina Willenberg, Stefanie Kiesler, Elisabeth Steinhagen‐Thiessen, Nils Helge Schebb, Ursula Kassner · 2019 · Nutrients
  141. S102 Lipoxin A4 Improves Efferocytosis Via Inhibition Of The Hmgb1 In Human Alveolar Macrophages
    Qikun Wang, Dhruv Parekh, V. D’Souza, Rachel C. A. Dancer, Jaimin Patel, Domokos Bartis, Fan Gao, Qingquan Lian, Shengwei Jin, DAVID R. THICKETT · 2014 · Thorax
  142. Differential behavior of sPLA2-V and sPLA2-X in human neutrophils
    I. Solodkin-Szaingurten, Rachel Lévy, Nurit Hadad · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  143. The association between atorvastatin administration and plasma total homocysteine levels in renal transplant recipients
    Ali Monfared, Seyyede Zeinab Azimi, Ehsan Kazemnejad · 2016 · Journal of Nephropathology
  144. LDL fatty acids composition as a risk biomarker of cardiovascular disease
    Hashem Nayeri, Gholam Ali Naderi, Asgari Sedigheh, Masoumeh Sadeghi, Maryam Boshtam, Samaneh Mohammadzadeh, Nasim Babaknejad · 2017 · Artery Research
  145. Phospholipase A2 as a therapeutic target for atherosclerosis
    Mahir Karakas, Wolfgang Köenig · 2010 · Clinical Lipidology
  146. Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol
    Kengo Moriyama, Eiko Takahashi · 2017 · Clinical Laboratory
  147. Effects of Extended-Release Niacin on Quartile Lp-PLA 2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial
    Radmila Lyubarova, John J. Albers, Santica M. Marcovina, Yao Yao, Ruth McBride, Alexandru Topliceanu, Todd J. Anderson, Jerome L. Fleg, Patrice M. Desvigne-Nickens, Moti L. Kashyap et al. · 2019 · Journal of Cardiovascular Pharmacology and Therapeutics
  148. Targeting myeloperoxidase enhances apoptosis in chemoresistant epithelial ovarian cancer cells by reversing s-nitrosylation of caspase-3
    Nicole M. Fletcher, Ira Memaj, Robert Tyler Morris, Ghassan M. Saed · 2018 · Gynecologic Oncology
  149. The value of apoA-I in predicting heart disease and myocardial infarction
    Caroline Bergstro Schmidt, Göran M.L. Bergström, Allan D. Sniderman · 2015 · Clinical Lipidology
  150. Oral Administration of Sustained Release Niacin Inhibits Platelet Aggregation
    Nicholas B. Norgard, Nicholas R. Bacon, Matthew Agosti · 2016 · Current Clinical Pharmacology
  151. Atherogenesis in human - clinical aspects of circulating immune complexes
    Ya D Babintseva, Анастасия Михайловна Сергеева, В П Карагодин, Alexander Nikolaevich Orekhov · 2016 · Clinical Medicine (Russian Journal)
  152. A novel phospholipase A2 has been cloned that is responsible for the increased lyso-phosphatidylcholine content of oxidatively modified LDL
    Colin H. Macphee, David G. Tew, Simon Q.J. Rice, G. Mark P. Lawrence, Christopher Southan, K.J. Milliner, Kitty Moores, H. Li, Israel Gloger · 1995 · Atherosclerosis
  153. LPS‐induced mTORC1 Signaling Activates Lipid Raft‐Actin Cytoskeletal Interactions for Phagocytosis through SREBP‐1a
    Jae‐Ho Lee, Do Young ‍Kim, Sun Hee Lee, Dae‐Kyu Song, Jae‐Hoon Bae, Seung‐Soon Im · 2019 · The FASEB Journal
  154. HNE contributes to macrophage foam cell formation through increased expression of SRA in ApoE‐deficient mice
    Chi Dae Kim, Mi Ran Yun, Dong‐Soon Im, Seong Jin Lee, Kyo Won Seo, Joong Won Woo, Sun Sik Bae · 2008 · The FASEB Journal
  155. Effect of niacin on oxidized low-density lipoprotein levels in Chinese patients with dyslipidaemia
    Miao Hu, Ya‐Ling Yang, Shizuya Yamashita, Daisaku Masuda, Brian Tomlinson · 2014 · Atherosclerosis
  156. Lp-PLA2 levels are independant of statin treatment in dyslipidemic patients
    David H. Rosenbaum, Alessandro Mattina, Randa Bittar, Éric Bruckert, Dominique Bonnefont‐Rousselot, Philippe Giral · 2015 · Atherosclerosis
  157. P3098Association with coronary high-intensity plaque on T1-weighted magnetic resonance imaging and circulating levels of malondialdehyde-modified low-density lipoprotein
    Daigo Hiraya, Akira Sato, Takuo Hoshi, Takako Ichinohe, Satoshi Sakai, Hiroaki Watabe, Masaki Ieda · 2019 · European Heart Journal
  158. Abstract 059: Deficiency of Either Prebiotic Dietary Fibre or Prebiotic-Responsive Gut Microbiota Result in High Blood Pressure
    Francine Z. Marques, Waled Shihata, Hamdi A. Jama, Kirill Tsyganov, Mark Ziemann, Helen Kiriazis, Duncan Horlock, Beverly Giam, Antony Vinh, Chad J Johnson et al. · 2019 · Hypertension